The Lancet Neurology in conversation with
Varighed i alt:
12 h 44 min
Amit Bar-Or on fenebrutinib for relapsing multiple sclerosis
The Lancet Neurology in conversation with
08:40
Marte-Helene Bjørk on reproductive risks in people with epilepsy
The Lancet Neurology in conversation with
20:40
Geoff Manley on a new classification system for traumatic brain injury
The Lancet Neurology in conversation with
25:34
Wayne Feng on stroke rehabilitation using brain stimulation and constraint-induced movement therapy
The Lancet Neurology in conversation with
19:52
Marialuisa Gandolfi on the management of chronic pain in Parkinson's disease
The Lancet Neurology in conversation with
12:43
Michael Tymianski on neuroprotection in stroke
The Lancet Neurology in conversation with
25:17
Elizabeth Finger on oxytocin for apathy in frontotemporal dementia
The Lancet Neurology in conversation with
18:43
The Lancet Neurology Editors on advances in neurology in 2024
The Lancet Neurology in conversation with
18:01
Florian Krismer and Elizabeth Coon on multiple system atrophy
The Lancet Neurology in conversation with
17:44
Suvankar Pal on the motor neuron disease trial MND-SMART
The Lancet Neurology in conversation with
18:20
Jorge Correale and Lilyana Amezcua on differential diagnosis of multiple sclerosis
The Lancet Neurology in conversation with
19:30
Alex Iranzo on sleep and Parkinson's disease
The Lancet Neurology in conversation with
17:14
Adrian Owen on detecting awareness after acute brain injury
The Lancet Neurology in conversation with
17:49
Glenn Nielsen on specialist physiotherapy for people with functional motor disorder
The Lancet Neurology in conversation with
15:58
Sanjay Sisodiya on climate change and brain health
The Lancet Neurology in conversation with
21:18
Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy
The Lancet Neurology in conversation with
23:58
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system
The Lancet Neurology in conversation with
25:48
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders
The Lancet Neurology in conversation with
12:50
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy
The Lancet Neurology in conversation with
22:15
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury
The Lancet Neurology in conversation with
18:54
Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage
The Lancet Neurology in conversation with
24:39
Njideka Okubadejo and Mie Rizig on Parkinson's disease in African and African admixed populations
The Lancet Neurology in conversation with
27:04
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis
The Lancet Neurology in conversation with
15:13
William Jagust on amyloid β and cognition
The Lancet Neurology in conversation with
14:06
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury
The Lancet Neurology in conversation with
15:04
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases
The Lancet Neurology in conversation with
17:50
Andrew Cole on the complexities underlying epilepsy in people with glioblastoma
The Lancet Neurology in conversation with
19:08
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation
The Lancet Neurology in conversation with
15:50
Kerstin Hellwig on family planning considerations in MS
The Lancet Neurology in conversation with
14:54
Geraldine Dawson on advances in the prediction of autism during infancy
The Lancet Neurology in conversation with
25:04
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke
The Lancet Neurology in conversation with
09:15
Beau Ances on amyloid biomarkers in Alzheimer’s
The Lancet Neurology in conversation with
12:04
Axel Petzold on the diagnosis and classification of optic neuritis
The Lancet Neurology in conversation with
20:33
Maeike Zijlmans on using biomarkers to tailor epilepsy surgery
The Lancet Neurology in conversation with
15:07
Jerome Siegel on sleep habits
The Lancet Neurology in conversation with
44:20
Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy
The Lancet Neurology in conversation with
17:43
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy
The Lancet Neurology in conversation with
23:28
Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies
The Lancet Neurology in conversation with
19:22
Mark Hallett on functional neurological disorder
The Lancet Neurology in conversation with
09:13
Eva Feldman on advances in understanding ALS
The Lancet Neurology in conversation with
23:13
